The relationship between regional abdominal fat distribution and both insulin resistance and subclinical chronic inflammation in non-diabetic adults

[1] Hung KC(2005)Obesity and its related diseases in Taiwan Obes Rev 6 271-274

[2] Langenberg C(2012)Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study PLoS Med 9 e1001230-S16

[3] Sharp SJ(2007)Abdominal adiposity and cardiometabolic risk: do we have all the answer? Am J Med 120 S10-1241

[4] Schulze MB(2013)Adipose tissue dysfunction in nascent metabolic syndrome J Obese 2013 393192-783

[5] Rolandsson O(2007)Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study Circulation 116 1234-1751

[6] Overvad K(2006)Adipocytokines: mediators linking adipose tissue, inflammation and immunity Nat Rev Immunol 6 772-169

[7] Forouhi NG(2008)Adipokines and insulin resistance Mol Med 14 741-E1760

[8] Spranger J(2012)Visceral fat mass is always, but adipokines (adiponectin and resistin) are diversely associated with insulin resistance in Chinese type 2 diabetic and normoglycemic subjects Diabetes Res Clin Pract 96 163-21988

[9] Drogan D(2011)Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity J Clin Endocrinol Metab 96 E1756-116

[10] Huerta JM(2010)Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study Obesity 18 2191-234

[1] Hung KC(2005)Obesity and its related diseases in Taiwan Obes Rev 6 271-274

[2] Langenberg C(2012)Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study PLoS Med 9 e1001230-S16

[3] Sharp SJ(2007)Abdominal adiposity and cardiometabolic risk: do we have all the answer? Am J Med 120 S10-1241

[4] Schulze MB(2013)Adipose tissue dysfunction in nascent metabolic syndrome J Obese 2013 393192-783

[5] Rolandsson O(2007)Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study Circulation 116 1234-1751

[6] Overvad K(2006)Adipocytokines: mediators linking adipose tissue, inflammation and immunity Nat Rev Immunol 6 772-169

[7] Forouhi NG(2008)Adipokines and insulin resistance Mol Med 14 741-E1760

[8] Spranger J(2012)Visceral fat mass is always, but adipokines (adiponectin and resistin) are diversely associated with insulin resistance in Chinese type 2 diabetic and normoglycemic subjects Diabetes Res Clin Pract 96 163-21988

[9] Drogan D(2011)Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity J Clin Endocrinol Metab 96 E1756-116

[10] Huerta JM(2010)Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study Obesity 18 2191-234